Rapport Therapeutics Inc.... (RAPP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
14.38
0.61 (4.43%)
At close: Jan 28, 2025, 1:58 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 |
Revenue | n/a | n/a |
Cost of Revenue | 112.00K | 15.00K |
Gross Profit | -112.00K | -15.00K |
Operating Income | -36.18M | -10.37M |
Interest Income | 2.53M | n/a |
Pretax Income | -34.78M | -10.65M |
Net Income | -34.79M | -10.65M |
Selling & General & Admin | 8.07M | 1.24M |
Research & Development | 28.00M | 9.12M |
Other Expenses | n/a | n/a |
Operating Expenses | 36.07M | 10.35M |
Interest Expense | n/a | 285.00K |
Selling & Marketing Expenses | -112.00K | n/a |
Cost & Expenses | 36.18M | 10.37M |
Income Tax | 10.00K | n/a |
Shares Outstanding (Basic) | 164.35M | 36.58M |
Shares Outstanding (Diluted) | 164.35M | 36.58M |
EPS (Basic) | -0.21 | -0.29 |
EPS (Diluted) | -0.21 | -0.29 |
EBITDA | -34.66M | -10.35M |
Depreciation & Amortization | 112.00K | 15.00K |